mRNA COVID-19
Vaccine Study
● Now Open in Washington, DC
People of any age — including children — can be infected with COVID-19. Infants with underlying conditions, such as asthma, may be at risk of developing severe symptoms when exposed to the virus. Meridian is now enrolling infants for a COVID-19 vaccine study.
Eligible participants…
- Must be age 12 weeks to <6 months
- Must NOT have had COVID-19 within the past 2 weeks
- Must NOT have received any vaccine within the past 2 weeks
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Submit your information
Study Location
Meridian Clinical Research (Pediatrics)
4850 Massachusetts Ave NW, 2nd Floor
Washington, DC 20016
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy